VivaVision Biotech is a clinical-stage R&D biopharmaceutical company.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 21, 2021 | Series D | ¥300M | 4 | — | — | Detail |
Sep 26, 2019 | Series C | ¥65M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
CFS Capital | — | Series D |
FengHe Fund Management | — | Series D |
Cenova Capital | — | Series D |
Beida Biomedical Industry Fund | — | Series D |
Donghan International | — | Series C |
Yingqi Investment | — | Series C |